Lam, A., Ozdemir, S., Verghese, N., Baid, D., Ganguly, S., Lee, P. C., … Goh, S.-Y. (2019). Impact of CV Mortality Risk Perception on Patient Preferences for Type 2 Diabetes Mellitus Pharmacotherapy. In CIRCULATION (Vol. 140).

Lam, Amanda, Semra Ozdemir, Naina Verghese, Drishti Baid, Sonali Ganguly, Phong Ching Lee, Adoree Y. Y. Lim, Ling Zhu, Eric Finkelstein, and Su-Yen Goh. “Impact of CV Mortality Risk Perception on Patient Preferences for Type 2 Diabetes Mellitus Pharmacotherapy.” In CIRCULATION, Vol. 140, 2019.

Lam A, Ozdemir S, Verghese N, Baid D, Ganguly S, Lee PC, et al. Impact of CV Mortality Risk Perception on Patient Preferences for Type 2 Diabetes Mellitus Pharmacotherapy. In: CIRCULATION. 2019.

Lam, Amanda, et al. “Impact of CV Mortality Risk Perception on Patient Preferences for Type 2 Diabetes Mellitus Pharmacotherapy.” CIRCULATION, vol. 140, 2019.

Lam A, Ozdemir S, Verghese N, Baid D, Ganguly S, Lee PC, Lim AYY, Zhu L, Finkelstein E, Goh S-Y. Impact of CV Mortality Risk Perception on Patient Preferences for Type 2 Diabetes Mellitus Pharmacotherapy. CIRCULATION. 2019.